Did you catch all of this week's top oncology news? Test your knowledge with OncLive's Weekly News Quiz.
Related to this article
The FDA has approved pembrolizumab plus enfortumab vedotin in MIBC.
Advertisement
Advertisement
Trending on OncLive
1
Dr Choueiri on the Phase 3 LITESPARK-022 Trial of Belzutifan Plus Pembrolizumab in ccRCC
2
Bexobrutideg Aims to Overcome Resistance Mutations in R/R CLL
3
Adjuvant Immunotherapy, Risk Stratification, and Multidisciplinary Care Redefine CSCC Management
4
BPM31510 Plus Chemoradiation Drives Encouraging OS Trend in Newly Diagnosed Glioblastoma
5